Los pacientes pueden enfrentar efectos secundarios, como nuseas, reflujo, calambres abdominales, retraso en el vaciamiento gstrico y estreimiento, que pueden afectar su capacidad o voluntad de continuar el tratamiento
Dovato, which combines the integrase strand transfer inhibitor dolutegravir with the nucleoside reverse transcriptase inhibitor lamivudine, was approved to treat HIV-1 infection in adolescents 12 years and older, making it the first oral, two-drug, single-tablet regimen available for this patient population, according to ViiV
If you have doses remaining as the BUD approaches, use them according to schedule but be extra diligent about storage
Antioxid (Basel) 10(9):1438
Variables including age, age at index event (GLP-1 analogs vs
The global increase in obesity and diabetes has turned these treatments into the most demanded medications